JP2015525207A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2015525207A5 JP2015525207A5 JP2015513349A JP2015513349A JP2015525207A5 JP 2015525207 A5 JP2015525207 A5 JP 2015525207A5 JP 2015513349 A JP2015513349 A JP 2015513349A JP 2015513349 A JP2015513349 A JP 2015513349A JP 2015525207 A5 JP2015525207 A5 JP 2015525207A5
- Authority
- JP
- Japan
- Prior art keywords
- compound
- stem cells
- group
- pluripotent stem
- undifferentiated
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- -1 2,4-dioxo-5-fluoropyrimidin-1-ylcarbonyl Chemical group 0.000 claims 11
- 150000001875 compounds Chemical class 0.000 claims 11
- 210000004027 cell Anatomy 0.000 claims 10
- 210000001778 pluripotent stem cell Anatomy 0.000 claims 7
- 229910052739 hydrogen Inorganic materials 0.000 claims 6
- 239000001257 hydrogen Substances 0.000 claims 6
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 4
- 150000002431 hydrogen Chemical class 0.000 claims 4
- 230000002062 proliferating effect Effects 0.000 claims 4
- 239000003112 inhibitor Substances 0.000 claims 3
- 230000002401 inhibitory effect Effects 0.000 claims 3
- 239000000203 mixture Substances 0.000 claims 3
- 125000004916 (C1-C6) alkylcarbonyl group Chemical group 0.000 claims 2
- BLNVISNJTIRAHF-UHFFFAOYSA-N 4-chlorobenzamide Chemical compound NC(=O)C1=CC=C(Cl)C=C1 BLNVISNJTIRAHF-UHFFFAOYSA-N 0.000 claims 2
- 101710159293 Acyl-CoA desaturase 1 Proteins 0.000 claims 2
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims 2
- 125000002334 N-hydroxyacetimidoyl group Chemical group [H]C([H])([H])C([*])=NO[H] 0.000 claims 2
- 206010028980 Neoplasm Diseases 0.000 claims 2
- 125000000217 alkyl group Chemical group 0.000 claims 2
- 125000003236 benzoyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C(*)=O 0.000 claims 2
- 201000011510 cancer Diseases 0.000 claims 2
- 231100000433 cytotoxic Toxicity 0.000 claims 2
- 230000001472 cytotoxic effect Effects 0.000 claims 2
- 201000010099 disease Diseases 0.000 claims 2
- 125000005843 halogen group Chemical group 0.000 claims 2
- 238000000034 method Methods 0.000 claims 2
- 125000005146 naphthylsulfonyl group Chemical group C1(=CC=CC2=CC=CC=C12)S(=O)(=O)* 0.000 claims 2
- 239000008194 pharmaceutical composition Substances 0.000 claims 2
- 230000035755 proliferation Effects 0.000 claims 2
- 230000035899 viability Effects 0.000 claims 2
- 102100028897 Stearoyl-CoA desaturase Human genes 0.000 claims 1
- 125000001309 chloro group Chemical group Cl* 0.000 claims 1
- 239000003814 drug Substances 0.000 claims 1
- 239000003937 drug carrier Substances 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims 1
- 238000012544 monitoring process Methods 0.000 claims 1
- 210000000130 stem cell Anatomy 0.000 claims 1
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201261650049P | 2012-05-22 | 2012-05-22 | |
| US61/650,049 | 2012-05-22 | ||
| US201261696387P | 2012-09-04 | 2012-09-04 | |
| US61/696,387 | 2012-09-04 | ||
| PCT/IL2013/050441 WO2013175474A2 (en) | 2012-05-22 | 2013-05-22 | Selective inhibitors of undifferentiated cells |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2015525207A JP2015525207A (ja) | 2015-09-03 |
| JP2015525207A5 true JP2015525207A5 (OSRAM) | 2016-07-07 |
| JP6293127B2 JP6293127B2 (ja) | 2018-03-14 |
Family
ID=48746093
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015513349A Expired - Fee Related JP6293127B2 (ja) | 2012-05-22 | 2013-05-22 | 未分化細胞の選択的阻害剤 |
Country Status (10)
| Country | Link |
|---|---|
| US (3) | US9456998B2 (OSRAM) |
| EP (1) | EP2852387A2 (OSRAM) |
| JP (1) | JP6293127B2 (OSRAM) |
| KR (1) | KR20150013777A (OSRAM) |
| CN (1) | CN104768549A (OSRAM) |
| BR (1) | BR112014029365A2 (OSRAM) |
| CA (1) | CA2873817A1 (OSRAM) |
| MX (1) | MX2014014174A (OSRAM) |
| RU (1) | RU2014149559A (OSRAM) |
| WO (1) | WO2013175474A2 (OSRAM) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP6293127B2 (ja) | 2012-05-22 | 2018-03-14 | イッサム リサーチ ディベロップメント カンパニー オブ ザ ヘブリュー ユニバーシティー オブ エルサレム リミテッド | 未分化細胞の選択的阻害剤 |
| CN103755618A (zh) * | 2013-12-19 | 2014-04-30 | 南京农业大学 | 一种含n-取代苯肼的吡咯烷-2,4-二酮类化合物、制备方法及应用 |
| US10316287B2 (en) | 2014-01-21 | 2019-06-11 | The Medical College Of Wisconsin, Inc. | Methods for selective inhibition of pluripotent stem cells |
| WO2016141299A1 (en) * | 2015-03-04 | 2016-09-09 | Children's Hospital Medical Center | Methods for treating cancer |
| CA2986930C (en) | 2015-06-24 | 2023-09-26 | Duke University | Chemical modulators of signaling pathways and therapeutic use |
| JP7123809B2 (ja) | 2016-12-20 | 2022-08-23 | 住友ファーマ株式会社 | 未分化ｉＰＳ細胞の除去剤 |
| JP2020514293A (ja) | 2017-01-06 | 2020-05-21 | ユマニティ セラピューティクス，インコーポレーテッド | 神経障害を治療する方法 |
| EP3634425A4 (en) * | 2017-06-07 | 2021-04-07 | Academia Sinica | METHOD OF ELIMINATION OF UNDIFFERENTIATED PLURIPOTENT STEM CELLS |
| EP3480296A1 (en) | 2017-11-06 | 2019-05-08 | Universität zu Köln | Diamines for use in the elimination of pluripotent stem cells |
| EP3768269B1 (en) | 2018-03-23 | 2025-08-20 | Janssen Pharmaceutica NV | Compounds and uses thereof |
| CN109402121A (zh) * | 2018-12-11 | 2019-03-01 | 宁夏医科大学总医院 | 一种环状RNA hsa_circSCD_004及其特异性扩增引物和应用 |
| MX2021008903A (es) | 2019-01-24 | 2021-11-04 | Yumanity Therapeutics Inc | Compuestos y usos de los mismos. |
| EA202192047A1 (ru) | 2019-11-13 | 2021-12-08 | Юманити Терапьютикс, Инк. | Соединения и их применение |
| CN119548487B (zh) * | 2024-12-05 | 2025-11-14 | 浙江工业大学 | 5-(十四烷氧基)-2-糠酸在制备抑制破骨细胞分化和功能的药物中的应用 |
Family Cites Families (64)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE1199540B (de) * | 1963-12-27 | 1965-08-26 | Schering Ag | Mittel mit Wirkung gegen echten Mehltau |
| US4032524A (en) * | 1973-11-28 | 1977-06-28 | Mitsui Toatsu Chemicals, Incorporated | 1-carbamoyl-5-fluorouracil derivatives |
| JPS53130679A (en) * | 1977-04-20 | 1978-11-14 | Mitsui Toatsu Chem Inc | Preparation of 1-carbamoyl-uracil |
| CA1177851A (en) * | 1980-07-02 | 1984-11-13 | Nicola Troiani | Fungicidally active arylhydrazoaldoximes and derivatives thereof |
| TW308598B (OSRAM) * | 1994-01-14 | 1997-06-21 | Hoffmann La Roche | |
| CA2328457A1 (en) | 1998-06-20 | 1999-12-29 | Washington University | Membrane-permeant peptide complexes for medical imaging, diagnostics, and pharmaceutical therapy |
| US20060210947A1 (en) | 2003-01-13 | 2006-09-21 | Lampert Christopher J | Endodontic instrument and instrument system |
| US7763618B2 (en) | 2003-07-29 | 2010-07-27 | Xenon Pharmaceuticals Inc. | Pyridyl derivatives and their use as therapeutic agents |
| TW201038270A (en) | 2003-07-30 | 2010-11-01 | Xenon Pharmaceuticals Inc | Pyridazine derivatives and their use in the inhibition of stearoyl-CoA desaturase |
| WO2005011656A2 (en) | 2003-07-30 | 2005-02-10 | Xenon Pharmaceuticals Inc. | Pyridyl derivatives and their use as therapeutic agents |
| SG145701A1 (en) | 2003-07-30 | 2008-09-29 | Xenon Pharmaceuticals Inc | Piperazine derivatives and their use as therapeutic agents |
| US7754711B2 (en) | 2003-07-30 | 2010-07-13 | Xenon Pharmaceuticals Inc. | Pyridazine derivatives and their use as therapeutic agents |
| US7514436B2 (en) | 2003-07-30 | 2009-04-07 | Xenon Pharmaceuticals Inc. | Pyridazine derivatives and their use as therapeutic agents |
| BRPI0418939A (pt) | 2004-07-06 | 2008-04-08 | Xenon Pharmaceuticals Inc | derivados de nicotinamida e sua utilização como agentes terapêuticos |
| US8071603B2 (en) | 2004-09-20 | 2011-12-06 | Xenon Pharmaceuticals Inc. | Heterocyclic derivatives and their use as stearoyl-CoA desaturase inhibitors |
| CA2580857A1 (en) | 2004-09-20 | 2006-09-28 | Xenon Pharmaceuticals Inc. | Heterocyclic derivatives and their use as stearoyl-coa desaturase inhibitors |
| CA2580855A1 (en) | 2004-09-20 | 2006-03-30 | Xenon Pharmaceuticals Inc. | Heterocyclic derivatives and their use as stearoyl-coa desaturase inhibitors |
| CN101084212A (zh) | 2004-09-20 | 2007-12-05 | 泽农医药公司 | 杂环衍生物及其作为硬脂酰CoA去饱和酶介导剂的用途 |
| TW200626138A (en) | 2004-09-20 | 2006-08-01 | Xenon Pharmaceuticals Inc | Heterocyclic derivatives and their use as therapeutic agents |
| MX2007003319A (es) | 2004-09-20 | 2007-06-05 | Xenon Pharmaceuticals Inc | Derivados heterociclicos y su uso como agentes terapeuticos. |
| BRPI0515477A (pt) | 2004-09-20 | 2008-07-22 | Xenon Pharmaceuticals Inc | derivados heterocìclicos bicìclicos e o uso dos mesmos como inibidores de estaroil-coa-desaturase (scd) |
| MX2007003318A (es) | 2004-09-20 | 2007-05-18 | Xenon Pharmaceuticals Inc | Derivados heterociclicos y su uso como agentes terapeuticos. |
| CN101090724A (zh) | 2004-09-20 | 2007-12-19 | 泽农医药公司 | 用于抑制人硬脂酰CoA去饱和酶的吡啶衍生物 |
| GT200600046A (es) | 2005-02-09 | 2006-09-25 | Terapia de combinacion | |
| GB0508472D0 (en) | 2005-04-26 | 2005-06-01 | Glaxo Group Ltd | Compounds |
| WO2006125194A2 (en) | 2005-05-19 | 2006-11-23 | Xenon Pharmaceuticals Inc. | Piperazine derivatives and their uses as therapeutic agents |
| WO2006125179A1 (en) | 2005-05-19 | 2006-11-23 | Xenon Pharmaceuticals Inc. | Tricyclic compounds and their uses as therapeutic agents |
| WO2007050124A1 (en) | 2005-05-19 | 2007-05-03 | Xenon Pharmaceuticals Inc. | Fused piperidine derivatives and their uses as therapeutic agents |
| WO2007044085A2 (en) | 2005-05-19 | 2007-04-19 | Xenon Pharmaceuticals Inc. | Heteroaryl compounds and their uses as therapeutic agents |
| WO2006125181A2 (en) | 2005-05-19 | 2006-11-23 | Xenon Pharmaceuticals Inc. | Piperidine derivatives and their use as stearoyl-coa desaturase modulators |
| WO2007046867A2 (en) | 2005-05-19 | 2007-04-26 | Xenon Pharmaceuticals Inc. | Piperidine derivatives and their uses as therapeutic agents |
| WO2006125178A2 (en) | 2005-05-19 | 2006-11-23 | Xenon Pharmaceuticals Inc. | Tricyclic pyridazine compounds and their uses as therapeutic agents |
| WO2006125180A1 (en) | 2005-05-19 | 2006-11-23 | Xenon Pharmaceuticals Inc. | Piperazine derivatives and their uses as therapeutic agents |
| WO2007046868A2 (en) | 2005-05-19 | 2007-04-26 | Xenon Pharmaceuticals Inc. | Thiazolidine derivatives and their uses as therapeutic agents |
| EP2029138A1 (en) | 2005-06-03 | 2009-03-04 | Xenon Pharmaceuticals Inc. | Aminothiazole derivatives as human stearoyl-coa desaturase inhibitors |
| EP1902051A1 (en) | 2005-06-09 | 2008-03-26 | Merck Frosst Canada Ltd. | Azacyclohexane derivatives as inhibitors of stearoyl-coenzyme a delta-9 desaturase |
| CA2615045A1 (en) | 2005-07-20 | 2007-01-25 | Merck Frosst Canada Ltd. | Heteroaromatic compounds as inhibitors of stearoyl-coenzyme a delta-9 desaturase |
| EP1951731A4 (en) | 2005-11-15 | 2010-07-07 | Merck Frosst Canada Ltd | AZACYCLOHEXANDERIVATES AS INHIBITORS OF STEAROYL-COENZYME-A-DELTA-9-DESATURASE |
| EP1966183A4 (en) | 2005-12-20 | 2010-12-29 | Merck Frosst Canada Ltd | HETEROAROMATIC COMPOUNDS AS INHIBITORS OF STEAROYL-COENZYME A-DELTA-9-DESATURASE |
| WO2007136746A2 (en) | 2006-05-19 | 2007-11-29 | Xenon Pharmaceuticals Inc. | Macrocyclic compounds and their uses as stearoyl-coa desaturase |
| JP2009537571A (ja) | 2006-05-22 | 2009-10-29 | メルク フロスト カナダ リミテツド | ステアロイル−コエンザイムａデルタ−９デサチュラーゼのインヒビターとしての環状アミン誘導体 |
| PL2029572T3 (pl) | 2006-06-05 | 2011-05-31 | Novartis Ag | Związki organiczne |
| WO2007143823A1 (en) | 2006-06-12 | 2007-12-21 | Merck Frosst Canada Ltd. | Azetidine derivatives as inhibitors of stearoyl-coenzyme a delta-9 desaturase |
| EP2032570A4 (en) | 2006-06-13 | 2010-10-27 | Merck Frosst Canada Ltd | AZACYCLOPENTATE DERIVATIVES AS INHIBITORS OF STEAROYL-COENZYME-A-DELTA-9-DESATURASE |
| WO2008003753A1 (en) | 2006-07-07 | 2008-01-10 | Biovitrum Ab (Publ) | Pyrazolo [1,5-a] pyrimidine analogs for use as inhibitors of stearoyl-coa desaturase (scd) activity |
| AU2007283401A1 (en) | 2006-08-09 | 2008-02-14 | Merck Frosst Canada Ltd. | Azacycloalkane derivatives as inhibitors of stearoyl-coenzyme A delta-9 desaturase |
| TWI404718B (zh) | 2006-08-15 | 2013-08-11 | Novartis Ag | 調節硬脂醯CoA去飽和酶活性之化合物及其用途 |
| MX2009002019A (es) | 2006-08-24 | 2009-03-09 | Novartis Ag | Derivados de 2-(pirazin-2-il)-tiazol y 2-(1h-pirazol-3-il)-tiazol asi como compuestos relacionados como inhibidores de la estearoil-coa-desaturasa (scd) para el tratamiento de trastornos metabolicos, cardiovasculares, y otros. |
| WO2008029266A1 (en) | 2006-09-08 | 2008-03-13 | Glenmark Pharmaceuticals S.A. | Stearoyl coa desaturase inhibitors |
| CA2662574A1 (en) | 2006-09-22 | 2008-03-27 | Novartis Ag | Heterocyclic organic compounds |
| US20090325956A1 (en) | 2006-10-13 | 2009-12-31 | Takahiko Taniguchi | Aromatic amine derivative and use thereof |
| JP2010506859A (ja) | 2006-10-20 | 2010-03-04 | メルク フロスト カナダ リミテツド | ステアロイル−コエンザイムａデルタ−９デサチュラーゼの阻害剤としてのアザシクロアルカン誘導体 |
| WO2008056687A1 (en) | 2006-11-09 | 2008-05-15 | Daiichi Sankyo Company, Limited | Novel spiropiperidine derivative |
| KR20090083477A (ko) | 2006-11-20 | 2009-08-03 | 그렌마크 파머수티칼스 에스. 아. | 스테아로일-ＣｏＡ 불포화효소 저해제인 아세틸렌 유도체 |
| TW200826936A (en) | 2006-12-01 | 2008-07-01 | Merck Frosst Canada Ltd | Azacycloalkane derivatives as inhibitors of stearoyl-coenzyme a delta-9 desaturase |
| MX2009006728A (es) | 2006-12-20 | 2009-09-09 | Novartis Ag | Heterociclos de 5 miembros 2-sustituidos como inhibidores de scd. |
| GB0625594D0 (en) | 2006-12-21 | 2007-01-31 | Smithkline Beecham Corp | Compounds |
| GB0625654D0 (en) | 2006-12-21 | 2007-01-31 | Smithkline Beecham Corp | Compounds |
| AR064965A1 (es) | 2007-01-26 | 2009-05-06 | Merck Frosst Canada Inc | Derivados de azacicloalcanos como inhibidores de estearoil - coenzima a delta -9 desaturasa |
| WO2008096746A1 (ja) | 2007-02-06 | 2008-08-14 | Takeda Pharmaceutical Company Limited | スピロ化合物およびその用途 |
| WO2009070533A1 (en) | 2007-11-29 | 2009-06-04 | Complegen, Inc. | Methods of inhibiting steroyl coa desaturase |
| WO2010144059A2 (en) * | 2009-06-12 | 2010-12-16 | Nanyang Polytechnic | Novel uses |
| US20120171213A1 (en) * | 2009-09-10 | 2012-07-05 | Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. | Method of treating tumors |
| JP6293127B2 (ja) | 2012-05-22 | 2018-03-14 | イッサム リサーチ ディベロップメント カンパニー オブ ザ ヘブリュー ユニバーシティー オブ エルサレム リミテッド | 未分化細胞の選択的阻害剤 |
-
2013
- 2013-05-22 JP JP2015513349A patent/JP6293127B2/ja not_active Expired - Fee Related
- 2013-05-22 US US14/402,467 patent/US9456998B2/en not_active Expired - Fee Related
- 2013-05-22 CN CN201380038889.6A patent/CN104768549A/zh active Pending
- 2013-05-22 EP EP13733462.9A patent/EP2852387A2/en not_active Withdrawn
- 2013-05-22 KR KR1020147035024A patent/KR20150013777A/ko not_active Withdrawn
- 2013-05-22 WO PCT/IL2013/050441 patent/WO2013175474A2/en not_active Ceased
- 2013-05-22 MX MX2014014174A patent/MX2014014174A/es unknown
- 2013-05-22 BR BR112014029365A patent/BR112014029365A2/pt not_active IP Right Cessation
- 2013-05-22 CA CA2873817A patent/CA2873817A1/en not_active Abandoned
- 2013-05-22 RU RU2014149559A patent/RU2014149559A/ru not_active Application Discontinuation
-
2016
- 2016-09-08 US US15/259,119 patent/US20170027890A1/en not_active Abandoned
-
2018
- 2018-02-01 US US15/885,872 patent/US20180153830A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2015525207A5 (OSRAM) | ||
| RU2014149559A (ru) | Селективные ингибиторы недифференцированных клеток | |
| JP2015528020A5 (OSRAM) | ||
| JP2014520248A5 (OSRAM) | ||
| PH12015500719A1 (en) | Gdf-8-inhibitors | |
| JP2017524735A5 (OSRAM) | ||
| EA202090291A3 (ru) | Производные бипиразола в качестве ингибиторов jak | |
| MX382171B (es) | Inhibidores de replicacion del virus de influenza. | |
| EA201792116A1 (ru) | Ингибитор янус-киназы | |
| MA37712A2 (fr) | Inhibiteurs macrocycliques de virus flaviviridae | |
| EA201591753A1 (ru) | 3-пиримидин-4-илоксазолидин-2-оны в качестве ингибиторов мутантного idh | |
| MX377916B (es) | Compuestos 4-amino-imidazoquinolina. | |
| EA201591745A1 (ru) | 3-пиримидин-4-ил-оксазолидин-2-оны в качестве ингибиторов мутантого idh | |
| CL2008001898A1 (es) | Compuestos derivados de pirazinona, inhibidores de p38; proceso de preparacion de estos; composicion farmaceutica que los comprende; combinacion farmaceutica que los comprende; uso para tratar enferemedades pulmonares obstructivas cronicas y asma. | |
| EA201790202A1 (ru) | Фталазиноны и изохинолиноны в качестве ингибиторов rock | |
| EA201500871A8 (ru) | Ингибиторы репликации вирусов гриппа | |
| MX370032B (es) | Agonistas del receptor de esfingosina-1-fosfato, metodos para prepararlos y composiciones farmaceuticas que contienen los mismos como un agente activo. | |
| PH12014501277A1 (en) | Kinase inhibitors | |
| CL2014001599A1 (es) | Compuestos derivados de nucleosidos sustituidos en 4’-azido, 3’-fluoro o sus sales, como inhibidores de la replicacion del rna del vhc; composicion farmaceutica que los comprende; y su uso para el tratamiento o la profilaxis de la infeccion por el virus de la hepatitis c (vhc). | |
| EA201790661A2 (ru) | Ингибиторы вируса гепатита c | |
| UA112795C2 (uk) | Біциклічні піразинонові похідні | |
| EA201301301A1 (ru) | Производные тиазола | |
| CL2013001591A1 (es) | Compuestos derivados de triazolopiridina; inhibidores de pde10a; proceso de obtencion; composicion farmaceutica; y uso en el tratamiento o profilaxis de trastornos psicoticos, esquizofrenia, ansiedad, entre otras enfermedades. | |
| EA201791021A1 (ru) | 1-[2-(АМИНОМЕТИЛ)БЕНЗИЛ]-2-ТИОКСО-1,2,3,5-ТЕТРАГИДРО-4H-ПИРРОЛО[3,2-d]ПИРИМИДИН-4-ОНЫ КАК ИНГИБИТОРЫ МИЕЛОПЕРОКСИДАЗЫ | |
| RU2016110874A (ru) | Комбинация ингибитора alk и ингибитора cdk для лечения клеточных пролиферативных заболеваний |